Acrobiosystems Limited 13654158 false 2023-10-01 2024-09-30 2024-09-30 The principal activity of the company is carrying out research and experimental development on biotechnology Digita Accounts Production Advanced 6.30.9574.0 true false true 13654158 2023-10-01 2024-09-30 13654158 2024-09-30 13654158 bus:OrdinaryShareClass1 2024-09-30 13654158 core:CurrentFinancialInstruments 2024-09-30 13654158 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 13654158 core:OfficeEquipment 2024-09-30 13654158 bus:SmallEntities 2023-10-01 2024-09-30 13654158 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 13654158 bus:FilletedAccounts 2023-10-01 2024-09-30 13654158 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 13654158 bus:RegisteredOffice 2023-10-01 2024-09-30 13654158 bus:Director1 2023-10-01 2024-09-30 13654158 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 13654158 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 13654158 bus:Agent1 2023-10-01 2024-09-30 13654158 core:OfficeEquipment 2023-10-01 2024-09-30 13654158 1 2023-10-01 2024-09-30 13654158 countries:EnglandWales 2023-10-01 2024-09-30 13654158 2023-09-30 13654158 core:OfficeEquipment 2023-09-30 13654158 2022-10-01 2023-09-30 13654158 2023-09-30 13654158 bus:OrdinaryShareClass1 2023-09-30 13654158 core:CurrentFinancialInstruments 2023-09-30 13654158 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 13654158 core:OfficeEquipment 2023-09-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13654158

Acrobiosystems Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 September 2024

 

Acrobiosystems Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 9

 

Acrobiosystems Limited

Company Information

Director

Y Chen

Registered office

2 Wetherby Way
Chessington
KT9 2LE

Accountants

Tally Wu Associates Limited
Chartered Certified Accountant2 Wetherby Way
Chessington
KT9 2LE

 

Acrobiosystems Limited

(Registration number: 13654158)
Balance Sheet as at 30 September 2024

Note

2024

2023

   

£

£

£

£

Fixed assets

   

 

Tangible assets

4

 

2,069

 

2,641

Current assets

   

 

Debtors

5

746,893

 

-

 

Cash at bank and in hand

 

198,990

 

35,715

 

 

945,883

 

35,715

 

Creditors: Amounts falling due within one year

6

(987,232)

 

(356,571)

 

Net current liabilities

   

(41,349)

 

(320,856)

Net liabilities

   

(39,280)

 

(318,215)

Capital and reserves

   

 

Called up share capital

7

10,000

 

10,000

 

Retained earnings

(49,280)

 

(328,215)

 

Shareholders' deficit

   

(39,280)

 

(318,215)

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 26 June 2025
 

Y Chen
Director

   
     
 

Acrobiosystems Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Wetherby Way
Chessington
KT9 2LE
United Kingdom

These financial statements were authorised for issue by the director on 26 June 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

 

Acrobiosystems Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

Going concern

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is calculated on a straight-line basis over the estimated useful life of the asset as shown below. The residual values are reviewed annually.

Asset class

Depreciation method and rate

Office equipment

Over 3 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Acrobiosystems Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Acrobiosystems Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

Financial instruments

The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


 Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amJrtised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

 Classification of financial liabilitiesFinancial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt Instruments are subsequently carried at amortised cost, using the effective Interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

 

Acrobiosystems Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 5 (2023 - 3).

 

Acrobiosystems Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

4

Tangible assets

Office equipment
£

Total
£

Cost or valuation

At 1 October 2023

3,433

3,433

Additions

700

700

At 30 September 2024

4,133

4,133

Depreciation

At 1 October 2023

792

792

Charge for the year

1,272

1,272

At 30 September 2024

2,064

2,064

Carrying amount

At 30 September 2024

2,069

2,069

At 30 September 2023

2,641

2,641

5

Debtors

Current

Note

2024
£

2023
£

Amounts owed by related parties

744,448

-

Prepayments

 

61

-

Other debtors

 

2,384

-

   

746,893

-

6

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Amounts owed to group undertakings and undertakings in which the company has a participating interest

979,749

350,920

Taxation and social security

 

6,033

-

Accruals and deferred income

 

1,450

1,450

Other creditors

 

-

4,201

 

987,232

356,571

 

Acrobiosystems Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

7

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

10,000

10,000

10,000

10,000

       

8

Parent and ultimate parent undertaking

The company's immediate parent is ACROBIOSYSTEMS HONGKONG LIMITED, incorporated in China.

 The ultimate parent is ACROBIOSYSTEMS CO.,LTD, incorporated in China.